- Home
- OCCI vs BDTX Comparison
OCCI vs BDTX Comparison
Compare OCCI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- BDTX
- Stock Information
- Founded
- OCCI N/A
- BDTX 2014
- Country
- OCCI United States
- BDTX United States
- Employees
- OCCI N/A
- BDTX N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OCCI Finance
- BDTX Health Care
- Exchange
- OCCI Nasdaq
- BDTX Nasdaq
- Market Cap
- OCCI 146.7M
- BDTX 144.9M
- IPO Year
- OCCI N/A
- BDTX 2020
- Fundamental
- Price
- OCCI $7.15
- BDTX $2.20
- Analyst Decision
- OCCI
- BDTX Strong Buy
- Analyst Count
- OCCI 0
- BDTX 4
- Target Price
- OCCI N/A
- BDTX $15.50
- AVG Volume (30 Days)
- OCCI 115.8K
- BDTX 478.7K
- Earning Date
- OCCI 12-11-2023
- BDTX 11-05-2024
- Dividend Yield
- OCCI 24.32%
- BDTX N/A
- EPS Growth
- OCCI N/A
- BDTX N/A
- EPS
- OCCI N/A
- BDTX N/A
- Revenue
- OCCI N/A
- BDTX N/A
- Revenue This Year
- OCCI N/A
- BDTX N/A
- Revenue Next Year
- OCCI $10.19
- BDTX N/A
- P/E Ratio
- OCCI N/A
- BDTX N/A
- Revenue Growth
- OCCI N/A
- BDTX N/A
- 52 Week Low
- OCCI $5.47
- BDTX $2.08
- 52 Week High
- OCCI $10.15
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- OCCI 44.75
- BDTX 38.39
- Support Level
- OCCI $7.04
- BDTX $2.08
- Resistance Level
- OCCI $7.19
- BDTX $2.24
- Average True Range (ATR)
- OCCI 0.11
- BDTX 0.16
- MACD
- OCCI -0.03
- BDTX 0.01
- Stochastic Oscillator
- OCCI 23.68
- BDTX 20.73
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.